6th CNS Partnering & Deal-Making
Conference - Boston, MA, USA
Over the past years, this partnering and business development conference has given global biotechnology and pharmaceutical companies an opportunity to network with high-level executives from top pharma and various biotech/pharmaceutical companies, as well as explore potential collaborations, and learn about relevant CNS disease issues that will affect the industry.
However, with the unmet need for CNS treatments growing, it is time to reevaluate how we partner with other stakeholders in the field to accelerate research. We will discuss research consortia, collaborations between academic centers and industry, and the growing role of patient groups and foundations. This meeting creates a space for leaders in the field to gather and invest in partnerships that will accelerate research and move the field forward.
An overview of the agenda:
I. Licensing and Partnering Strategies
II. Recent Advances in CNS Development
Panel: Current and Future Trends in CNS Development
Panel: Partnering in the AD, PD and other Cognitive Disorders. How Have Things Changed?
Panel: Investment Opportunities with Venture Capital
Panel: The Role of Foundations and Patient Groups in Research
(Photo Courtesy of Taj Boston, via travelandleisure.com)
Sep 09, 2013 to Sep 10, 2013
Taj Boston, 15 Arlington Street, Boston, MA 02116
Contact: (infogtcbio@gtcbio.com)
If you'd like to ask a question or post a comment about this talk please do so below.
This seminar posting is brought to you by Biotechnology Calendar, Inc. providing access to research information and research tools for nearly 20 years. Visit our Science Market Update Blog for current science funding and market information or see our schedule of upcoming science research laboratory product shows.
